Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California. Show more

Location: 2269 Chestnut Street, San Francisco, CA, 94123, United States | Website: https://www.hims.com | Industry: Drug Manufacturers - Specialty & Generic | Sector: Healthcare


Market Cap

9.741B

52 Wk Range

$19.15 - $72.98

Previous Close

$42.79

Open

$44.10

Volume

36,095,536

Day Range

$43.68 - $46.82

Enterprise Value

12.98B

Cash

629.7M

Avg Qtr Burn

N/A

Insider Ownership

6.29%

Institutional Own.

81.42%

Qtr Updated

09/30/25


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date